HHS RFI on Review and Revision of the Screening Framework Guidance

Publication Date: October 2020

Many synthetic DNA synthesis companies screen their customers and the sequences they order in accordance with Guidance from the US Department of Health and Human Services. However, current guidance was issued in 2010 and thus is out of date. EBRC’s response to this RFI describes important considerations for updating the Guidance.

Keywords:

Disclaimer: The following publications are intended for personal use. All persons reproducing, redistributing, or making commercial use of this information are expected to adhere to the terms and conditions as asserted by the copyright holder. Transmission or reproduction of protected items beyond that are allowed by fair use as defined in the copyright laws requires the written permission of the copyright owners.